Top Story
March 22, 2019
Read the
Perspective
from
Leonard R. Krilov, MD, FAAP, FIDSA, FPIDS
GlaxoSmithKline’s measles, mumps and rubella vaccine was found to be safe and effective in healthy children in a phase 3 clinical trial.
The findings of the study were previously presented at IDWeek and have now been published in the Journal of the Pediatric Infectious Diseases Society.
FDA News
March 22, 2019
The FDA’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted unanimously today to approve a new H3N2 component for next season’s…
In the Journals
March 22, 2019
The Infectious Diseases Society of America has issued updated clinical practice guidelines for the management of asymptomatic bacteriuria, or ASB. The new guidance adds…
In the Journals
March 22, 2019
Although rates of bacterial meningitis are low among neonates and infants, researchers estimated that febrile children in the first month of life are at nearly twice the…
In the Journals
March 22, 2019
Analysis indicated that childhood maltreatment may lead to changes in brain structure that in turn increase the risk for future relapse in patients with major…